Telomere 3′ overhang‐specific DNA oligonucleotides induce autophagy in malignant glioma cells
The DOI matches its Crossref record; 6 of the 6 references it cites were found in a registry or an index.
Abstract
Telomere 3′ overhang‐specific DNA oligonucleotides (T‐oligos) induce cell death in cancer cells, presumably by mimicking telomere loop disruption. Therefore, T‐oligos are considered an exciting new therapeutic strategy. The purpose of this study was to elucidate how T‐oligos exert antitumor effects on human malignant glioma cells in vitro and in vivo . We demonstrated that T‐oligos inhibited the proliferation of malignant glioma cells through induction of non‐apoptotic cell death and mitochondria hyperpolarization, whereas normal astrocytes were resistant to T‐oligos. Tumor cells treated with T‐oligos developed features compatible with autophagy, with development of autophagic vacuoles and conversion of an autoph‐agy‐related protein, microtubule‐associated protein 1 light chain 3 from type I (cytoplasmic form) to type II (membrane form of autophagic vacuoles). A reversephase protein microarray analysis and Western blotting revealed that treatment with T‐oligos inhibited the mammalian target of the rapamycin (mTOR) and the signal transducer and activator of transcription 3 (STAT3). Moreover, pretreatment with T‐oligos significantly prolonged the survival time of mice inoculated intracranially with malignant glioma cells compared with that of untreated mice and those treated with control oligonucleotides ( P = 0.0065 and P= 0.043, respectively). These results indicate that T‐oligos stimulate the induction of nonapoptotic autophagic also known as type II programmed cell death and are thus promising in the treatment of malignant glioma.—Aoki, H., Iwado, E., Eller, M. S., Kondo, Y., Fujiwara, K., Li, G.‐Z., Hess, K. R., Siwak, D. R., Sawaya, R., Mills, G. B., Gilchrest, B. A., Kondo, S. Telomere 3′ overhang‐specific DNA oligonucleotides induce autophagy in malignant glioma cells. FASEB J. 21, 2918–2930 (2007)
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Structure and function of telomeres
Blackburn, E. H. (1991) · Nature · doi:10.1038/350569a0 · Cited by 3,596
Mammalian Telomeres End in a Large Duplex Loop
Griffith, J. D., Comeau, L., Rosenfield, S., Stansel, R. M., Bianchi, A., Moss, H., & de Lange, T. (1999) · Cell · doi:10.1016/s0092-8674(00)80760-6 · Cited by 2,447 · cited 2×
“The 3 end of each telomere forms a loop structure with the double-stranded chromosome folded back and the loop is secured by insertion of the 3 overhang into the duplex region ( 8 ).”
BackgroundCounter, C. M., Avilion, A. A., LeFeuvre, C. E., Stewart, N. G., Greider, C. W., Harley, C. B., & Bacchetti, S. (1992) · The EMBO Journal · doi:10.1002/j.1460-2075.1992.tb05245.x · Cited by 2,096 · cited 1×
“meres to compensate for the progressive loss (5, 6).”
BackgroundTRF2 Protects Human Telomeres from End-to-End Fusions
van Steensel, B., Smogorzewska, A., & de Lange, T. (1998) · Cell · doi:10.1016/s0092-8674(00)80932-0 · Cited by 1,709
Dissection of Autophagosome Formation Using Apg5-Deficient Mouse Embryonic Stem Cells
Mizushima, N., Yamamoto, A., Hatano, M., Kobayashi, Y., Kabeya, Y., Suzuki, K., Tokuhisa, T., Ohsumi, Y., & Yoshimori, T. (2001) · The Journal of Cell Biology · doi:10.1083/jcb.152.4.657 · Cited by 1,361
p53- and ATM-Dependent Apoptosis Induced by Telomeres Lacking TRF2
Karlseder, J., Broccoli, D., Dai, Y., Hardy, S., & de Lange, T. (1999) · Science · doi:10.1126/science.283.5406.1321 · Cited by 1,086
Cited by
Discovery and development of the G-rich oligonucleotide AS1411 as a novel treatment for cancer
Bates, P. J., Laber, D. A., Miller, D. M., Thomas, S. D., & Trent, J. O. (2009) · Experimental and Molecular Pathology · doi:10.1016/j.yexmp.2009.01.004 · Cited by 874
Broad targeting of resistance to apoptosis in cancer
Mohammad, R. M., Muqbil, I., Lowe, L., Yedjou, C., Hsu, H.-Y., Lin, L.-T., Siegelin, M. D., Fimognari, C., Kumar, N. B., Dou, Q. P., et al. (2015) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2015.03.001 · Cited by 864
Targeting telomeres and telomerase
De Cian, A., Lacroix, L., Douarre, C., Temime-Smaali, N., Trentesaux, C., Riou, J.-F., & Mergny, J.-L. (2008) · Biochimie · doi:10.1016/j.biochi.2007.07.011 · Cited by 572
Anti- and pro-tumor functions of autophagy
Morselli, E., Galluzzi, L., Kepp, O., Vicencio, J.-M., Criollo, A., Maiuri, M. C., & Kroemer, G. (2009) · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research · doi:10.1016/j.bbamcr.2009.01.006 · Cited by 375
Single-cell proteomic chip for profiling intracellular signaling pathways in single tumor cells
Shi, Q., Qin, L., Wei, W., Geng, F., Fan, R., Shik Shin, Y., Guo, D., Hood, L., Mischel, P. S., & Heath, J. R. (2012) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1110865109 · Cited by 318
Moussay, E., Kaoma, T., Baginska, J., Muller, A., Van Moer, K., Nicot, N., Nazarov, P. V., Vallar, L., Chouaib, S., Berchem, G., et al. (2011) · Autophagy · doi:10.4161/auto.7.7.15454 · Cited by 125
ssDNA fragments induce cell senescence by telomere uncapping
Tsolou, A., Passos, J. F., Nelson, G., Arai, Y., & Zglinicki, T. V. (2008) · Experimental Gerontology · doi:10.1016/j.exger.2008.08.043 · Cited by 18
Metadata
- Authors
- Aoki, H., Iwado, E., Eller, M. S., Kondo, Y., Fujiwara, K., Li, G., Hess, K. R., Siwak, D. R., Sawaya, R., Mills, G. B., Gilchrest, B. A., & Kondo, S.
- Venue
- The FASEB Journal
- Publisher
- Wiley
- Published
- 2007-04-20
- Volume
- 21
- Issue
- 11
- Pages
- 2918-2930
- ISSN
- 0892-6638 (ISSN-L)
- 1530-6860
- OpenAlex
- W2016199934
- Cited by
- 67
- References
- 6
- FWCI
- 5.93
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.